StockData
Vertex Pharmaceuticals Inc logo

Vertex Pharmaceuticals Inc

VRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026Score 15/3036% above fair value
$553.15−5.73 (-1.03%)

Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –

Vertex Pharmaceuticals PP&E gross by Quarter

PP&E gross — Furniture and fixtures (standalone historical, $M) ($M)

Vertex Pharmaceuticals PP&E gross: $407M in Q4 2021, up 17.5% from a year earlier. No newer figure appears in the documents we track.

Latest, Q4 2021
407
Period ended Dec 31, 2021
Change on a year earlier
+17.5%
347 in Q4 2020
History
7 quarters
Since Q4 2015
Sources
6
Documents cited below

Where the Q4 2021 figure comes from

Source: Form 10-K (filed 2022-02-09) ↗

Reported in Form 10-K Note (Property and Equipment).

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedPP&E gross — Furniture and fixtures (standalone historical, $M) ($M)Year on yearSource
Q4 2021Dec 31, 2021407+17.5%Form 10-K (filed 2022-02-09) ↗
Q4 2020Dec 31, 2020347+9.2%Form 10-K (filed 2022-02-09) ↗
Q4 2019Dec 31, 2019318+13.1%Form 10-K (filed 2021-02-11) ↗
Q4 2018Dec 31, 2018281+9.5%Form 10-K (filed 2020-02-13) ↗
Q4 2017Dec 31, 2017257+8.4%Form 10-K (filed 2019-02-13) ↗
Q4 2016Dec 31, 2016237+8.2%Form 10-K (filed 2018-02-15) ↗
Q4 2015Dec 31, 2015219–Form 10-K (filed 2017-02-23) ↗

Cite this data

StockData. (2026). Vertex Pharmaceuticals PP&E gross ($M), quarterly Q4 2015–Q4 2021 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/ppe-gross-furn-hist

See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.